61.13
-0.13 (-0.21%)
| Previous Close | 61.26 |
| Open | 60.82 |
| Volume | 59 |
| Avg. Volume (3M) | 3,136 |
| Market Cap | 16,362,277,888 |
| Price / Earnings (TTM) | 10.10 |
| 52 Weeks Range | |
| Earnings Date | 30 Apr 2025 - 5 May 2025 |
| Profit Margin | 13.83% |
| Operating Margin (TTM) | 22.17% |
| Diluted EPS (TTM) | 6.05 |
| Quarterly Revenue Growth (YOY) | -1.20% |
| Quarterly Earnings Growth (YOY) | -18.50% |
| Total Debt/Equity (MRQ) | 54.80% |
| Current Ratio (MRQ) | 3.24 |
| Operating Cash Flow (TTM) | 1.13 B |
| Levered Free Cash Flow (TTM) | 775.88 M |
| Return on Assets (TTM) | 6.92% |
| Return on Equity (TTM) | 11.77% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (GB) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bearish | Bearish | |
| Stock | HOLOGIC INC HOLOGIC ORD SHS | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 3.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.0 |
| Average | 0.25 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| HOLOGIC INC HOLOGIC ORD SHS | 16 B | - | 10.10 | - |
| BECTON DICKINSON AND CO BECTON | 47 B | 2.27% | 27.35 | - |
| RESMED INC RESMED ORD SHS | 35 B | 0.80% | 47.35 | - |
| CONVATEC GROUP PLC ORD 10P | 5 B | 0.02% | 37.49 | 4.38 |
| COOPER COMPANIES INC COOPER ORD | 4 B | - | 4.31 | - |
| TECAN GROUP AG TECAN GROUP ORD | 2 B | 1.87% | 16.55 | - |
|
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Mid Core |
| % Held by Insiders | 0.86% |
| % Held by Institutions | 102.61% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |